Note: Ingredients listed on restricted chemical lists
EC/CAS
247-500-7/26172-55-4
Name of the chemical
5-chloro-2-methyl-4-thiazoline-3-ketone
Concentration
<0.1
General Information
Version
2.0
Revision date
2025-09-08
Product name
BioKits Allergen Swabbing Kit (swabs, tubes and buffer)
Emergency telephone
1-800-498-5743, 1-651-523-0318, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Neogen Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
sds@neogen.com
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture Classification according to GB CLP (SI 2019:720 as amended) Hazardous to the aquatic environment – Chronic Hazard, Category 3 H412 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to GB CLP (SI 2019:720 as amended)
Hazard statements
H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P273 - Avoid release to the environment. P501 - Dispose of contents and container to a hazardous or special waste collection point, in accordance with local, regional, national and international regulations.
Results of PBT and vPvB assessment
Component Substance(s) not meeting the PBT criteria of UK 2-Methyl-5-chloro-3-isothiazolone (26172-55-4), Copper dinitrate (3251-23-8), Di-sodium REACH regulation, in accordance with Annex XIII hydrogen phosphate (10028-24-7) Component Substance(s) not meeting the vPvB criteria of UK 2-Methyl-5-chloro-3-isothiazolone (26172-55-4), Copper dinitrate (3251-23-8), Di-sodium REACH regulation, in accordance with Annex XIII hydrogen phosphate (10028-24-7) Results of Endocrine Disruptor assessment Component Substance(s) not considered as endocrine disrupting. Di-sodium hydrogen phosphate(10028-24-7), 2-Methyl-5-chloro-3-isothiazolone(26172-55- They are not included in the list established in 4), Copper dinitrate(3251-23-8) accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, nor identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP
2.1 Classification of the substance or mixture
Classification according to GB CLP (SI 2019:720 as amended) Hazardous to the aquatic environment – Chronic Hazard, Category 3 H412 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
